See comments above on the promising use of oral miltefosine. Mucosal leishmaniasis is, itself, a complication. Secondary infections and associated problems are common. Culture and serologic tests are usually necessary. Treatment is difficult and cure rates decrease with advanced disease.
Treatment is as for cutaneous leishmaniasis.
Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion. Practical guide for the treatment of leishmaniasis. Journal of the American Academy of Dermatology. W.B. Saunders Company. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.